ArticleOncotarget2018
The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension.
Frank Erhard Uschner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleOncotarget2018
Frank Erhard Uschner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.